Novo Nordisk nails another phase III study of once-weekly insulin
![Photo: Mads Claus Rasmussen//](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14286432.ece/ALTERNATES/schema-16_9/doc7m69ys6rl8g1aah9r1oe.jpg)
On Monday, Novo Nordisk announced a success, reporting positive top-line results for a phase IIIa trial of once-weekly insulin icodec in a company press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk has twin successes with once-weekly insulin
For subscribers